These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [TNFalpha inhibitors for the treatment of rheumatoid arthritis]. Sany J, Kaiser MJ. Ann Med Interne (Paris); 2002 Feb; 153(1):34-40. PubMed ID: 11994688 [Abstract] [Full Text] [Related]
25. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S. Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [Abstract] [Full Text] [Related]
26. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis. Sendur OF, Turan Y, Berkit IK, Tastaban E. Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261 [Abstract] [Full Text] [Related]
31. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA. Scand J Rheumatol; 2009 Mar; 38(5):328-31. PubMed ID: 19579151 [Abstract] [Full Text] [Related]
32. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab. Diaz JC, Vallejo S, Cañas CA. Rheumatol Int; 2012 Oct; 32(10):3315-7. PubMed ID: 21881980 [Abstract] [Full Text] [Related]
33. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis]. Baba N, Nomura T, Sakemi T, Uchida M, Watanabe T. Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943 [Abstract] [Full Text] [Related]
34. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis]. Kawano M, Nomura H, Iwainaka Y, Nakashima A, Koni I, Tofuku Y, Takeda R. Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598 [Abstract] [Full Text] [Related]
35. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045 [Abstract] [Full Text] [Related]
36. Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy. Busch M, Rüster C, Schinköthe C, Gerth J, Wolf G. Clin Nephrol; 2013 Aug; 80(2):105-13. PubMed ID: 23587125 [Abstract] [Full Text] [Related]
37. [Case of rheumatoid arthritis with various histological lesions of the kidney]. Honma M, Toyoda M, Miyauchi M, Yamamoto N, Kimura M, Maruyama M, Nishina M, Yagame M, Endo M, Sakai H, Suzuki D. Nihon Jinzo Gakkai Shi; 2006 Aug; 48(2):67-73. PubMed ID: 16541759 [Abstract] [Full Text] [Related]
38. Membranous glomerulonephritis with the use of etanercept in ankylosing spondylitis. Kaushik P, Rahmani M, Ellison W. Ann Pharmacother; 2011 Dec; 45(12):e62. PubMed ID: 22116994 [Abstract] [Full Text] [Related]
39. Membranous nephropathy with crescents in rheumatoid arthritis: a case report. Dohi K, Shiiki H, Kawano T, Kanauchi M, Ishikawa H, Watanabe T. Nihon Jinzo Gakkai Shi; 1991 May; 33(5):523-7. PubMed ID: 1895551 [Abstract] [Full Text] [Related]
40. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Glace B, Gottenberg JE, Mariette X, Philippe R, Pereira B, Lequerré T, Berthelot JM, Dougados M, Toussirot E, Pham T, Allanore Y, Loeuille D, Euller-Ziegler L, Soubrier M. Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]